Sensorion Gets France Trial Approval for SENS-601 Gene Therapy
Sensorion, Montpellier, France & Cambridge, Mass., September 3, 2026 Sensorion announced that it has received Clinical Trial Authorization (CTA)...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Sensorion, Montpellier, France & Cambridge, Mass., September 3, 2026 Sensorion announced that it has received Clinical Trial Authorization (CTA)...
ARC-SUR-TILLE, France, July 6, 2026 Movmedix, the French orthopedic medical technology company behind the globally recognized LARS® synthetic ligament...
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSenseâ„¢ cryoablation system in...
